[1]
“Prospective Study to Ascertain the Advantages of Adding Neprilysin Inhibitor to Standard Care Among Patients with Congestive Cardiac Failure”, ijmhs, vol. 12, no. 05, pp. 1903–1909, May 2022, Accessed: Oct. 23, 2026. [Online]. Available: http://innovativejournal.in/index.php/ijmhs/article/view/3440